Stocks:
5,167
ETFs:
2,288
Exchanges:
11
Market Cap:
$62.22T
24h Vol:
$9.44B
Dominance:
MSFT:4.87%
Stocklytics Platform
Instrument logo  BIOL
Biolase
BIOL
58 / 100
Penny Stock
$0.15arrow_drop_up0.73%$0.00

Performance History

Stocklytics logo
Key Stats
Open$0.13
Prev. Close$0.15
EPS-29.44
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap4622709.00
PE Ratio-
LOWHIGH
Day Range0.13
0.15
52 Week Range0.13
47.00
Ratios
P/B Ratio0.77
Revenue-
Operating M. %-34.66%
Earnings$0.00
Earnings Growth %27.95%
EBITDA Margin %-28.35%
ROE %-602.83%
EPS-29.44

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

58vs 54. Market Avg.

All Score 58 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

BIOLMARKET
Value6539
Quality4440
Ownership317
Growth5346
Dividends-38
check_circle

Biolase 's Price discount from all time high of 100% is great compared to market average of 43.18%. This indicates BIOL could be a good value stock.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$726.31
24H (%)arrow_drop_down2.63%
24H ($)-$19.64
MARKET CAP$690.55B
PRICE$501.13
24H (%)arrow_drop_up1.61%
24H ($)$7.95
MARKET CAP$462.00B
PRICE$147.91
24H (%)arrow_drop_up1.48%
24H ($)$2.17
MARKET CAP$356.43B
PRICE$125.78
24H (%)arrow_drop_up0.43%
24H ($)$0.55
MARKET CAP$318.60B

About Biolase (BIOL)

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, therapy pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. John R. Beaver
Headquarters
Foothill Ranch
Employees
188
Exchange
NASDAQ
add Biolase  to watchlist

Keep an eye on Biolase

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Biolase 's (BIOL) price per share?

The current price per share for Biolase (BIOL) is $0.14. The stock has seen a price change of -$0.01 recently, indicating a -6.67% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Biolase (BIOL)?

For Biolase (BIOL), the 52-week high is $47, which is 33.47K% from the current price. The 52-week low is $0.13, the current price is 7.69% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Biolase (BIOL) a growth stock?

Biolase (BIOL) has shown an average price growth of -85.03% over the past three years. It has received a score of -6 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Biolase as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Biolase (BIOL) stock price performance year to date (YTD)?

As of the latest data, Biolase (BIOL) has a year-to-date price change of -87.04%. Over the past month, the stock has experienced a price change of -21.48%. Over the last three months, the change has been -84.78%. Over the past six months, the figure is -91.46%.

help
Is Biolase (BIOL) a profitable company?

Biolase (BIOL) has a net income of -$20.63M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 34.02% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -34.66% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 1.45%, providing insight into the company's sales performance and growth. The gross profit is $16.72M. Operating income is noted at -$17.94M. Furthermore, the EBITDA is -$13.94M.

help
What is the market capitalization of Biolase (BIOL)?

Biolase (BIOL) has a market capitalization of $4.62M. The average daily trading volume is 1.47M, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.